Exchange: NYSE·Updated 07:30 PM EDT
BLCO logo

BLCO Bausch + Lomb Corp.

$16.80
$0.05
(0.30%)
Today
Closed $16.80
$0.00
(0.00%)
After Hours
EarningsOct 28
Mkt Cap$6.02B
Vol482,801.00

About BLCO

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.
47

Neutral Sentiment

How do you feel about BLCO?

Axos300
$BLCO Looking at the 483 along side the warning letter. These guys are going on consent decree. Watch. It's just a matter if it's just the one site, the drug sites or the entire company.
Axos300
$BLCO I said it before, and I'll say it again. Entire leadership needs to be wiped out. The warning letter further proves it. Every. Single. Thing. They knew about and had been raised in the past.
TickrTalk0007
$BLCO when you have nothing innovative in your pipeline, you throw good money at bad data and try to revive the pipeline.... wasting money on failed Ph 2
Stock_Spectator
$BLCO $BHC Thomas J. Appio is the Chairman of the Board of Bausch + Lomb Corporation (NYSE: BLCO).He assumed the role on August 10, 2026, succeeding Brent Saunders, who continues to serve as a member of the board while remaining the company's Chief Executive Officer. Appio is also the CEO of Bausch Health Companies Inc.

Advertisement|Remove ads.